Anti-VEGF Injection Frequency and Visual Outcomes

An Evaluation of Clinical Trials and Routine Clinical Practice. Free dinner event, February 24, 2017. Click to Register Today!

Redirects with Article Web url, below. 

Related Videos
Related Content

BNS Ophthalmics created to leverage nanotechnology in the development of ophthalmic pharmaceutical products.

June 9th 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US

June 9th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Texas ophthalmologist’s license suspended after domestic violence arrest

June 8th 2023

OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101

June 8th 2023

BNS Ophthalmics created to leverage nanotechnology in the development of ophthalmic pharmaceutical products.

June 9th 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US

June 9th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Texas ophthalmologist’s license suspended after domestic violence arrest

June 8th 2023

OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101

June 8th 2023

BNS Ophthalmics created to leverage nanotechnology in the development of ophthalmic pharmaceutical products.

June 9th 2023

Podcast: Wet AMD and the treatment burden on patients

May 3rd 2023

Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US

June 9th 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Texas ophthalmologist’s license suspended after domestic violence arrest

June 8th 2023

OKYO Pharma announces dosing of first patient in randomized portion of phase 2 trial of OK-101

June 8th 2023
© 2023 MJH Life Sciences

All rights reserved.